Literature DB >> 2515304

An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis.

R A Drongowski1, A G Coran.   

Abstract

The risk of developmental of total parenteral nutrition (TPN)-associated cholestatic jaundice in neonates receiving intravenous hyperalimentation is high. Numerous factors have been cited as contributing to TPN cholestasis; however, the exact etiology remains obscure. This retrospective study was undertaken in order to identify any factors which might contribute to this syndrome. The hospital records of 172 neonates requiring TPN for a minimum of 1 week were reviewed. In addition, a subgroup of 32 infants requiring TPN for a minimum of 7 weeks was also examined. Cholestasis was defined as a direct serum bilirubin greater than 2.0 mg/dl during the course of TPN therapy. Significant factors for the development of cholestasis in both groups (n = 172, n = 32) included: number of operations (2.56 vs. 1.08, p = 0.0000), the number of days the patients received antibiotics (40.3 vs 12.9, p = 0.0000), and delayed start of enteral feedings (33.8 vs 14.1, p = 0.0000). Fifteen of the 32 patients who received TPN for at least 7 weeks did not develop cholestasis. In this subgroup (n = 32), there were no differences in birth weight, gestational age, days from birth to the start of TPN, or respiratory distress between those who developed cholestasis and those who remained anicteric. In contrast, there were significant differences between the cholestasis and noncholestasis groups in number of operations (13 vs 6, p = 0.0407), and days until enteral feedings were started (33.1 vs 18.9, p = 0.0289). This study suggests that the factor(s) contributing to the development of TPN-associated cholestasis are likely multifactorial. There appears to be a direct correlation between increasing severity of cholestatic jaundice and duration of TPN. This review does add a new parameter to the various causative factors suggested, namely the number of operative procedures. This new variable could be related to the stress of surgery itself or to the repeated administration of anesthetic agents.

Entities:  

Mesh:

Year:  1989        PMID: 2515304     DOI: 10.1177/0148607189013006586

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  15 in total

1.  Alteration of canalicular transporters in a mouse model of total parenteral nutrition.

Authors:  Yuko Tazuke; Daniel H Teitelbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

2.  Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure-Associated Liver Disease in Surgical Infants.

Authors:  Darla R Shores; Samuel M Alaish; Susan W Aucott; Janine E Bullard; Courtney Haney; Heidi Tymann; Bareng A S Nonyane; Kathleen B Schwarz
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

3.  Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome.

Authors:  Simon P Horslen; Debra L Sudan; Kishore R Iyer; Stuart S Kaufman; Angie K Iverson; Ira J Fox; Byers W Shaw; Alan N Langnas
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Pediatric short bowel syndrome: redefining predictors of success.

Authors:  Ariel U Spencer; Andreea Neaga; Brady West; Jared Safran; Pamela Brown; Imad Btaiche; Barbara Kuzma-O'Reilly; Daniel H Teitelbaum
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

5.  Taurine and cholestasis associated to TPN. Experimental study in rabbit model.

Authors:  J M Moran; J Salas; F Botello; E Macià; V Climent
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

Review 6.  Nutrition support in a surgical patient.

Authors:  B R Thapa; Sujit Jagirdhar
Journal:  Indian J Pediatr       Date:  2002-05       Impact factor: 1.967

7.  Total parenteral nutrition leads to alteration of hepatocyte cell cycle gene expression and proliferation in the mouse.

Authors:  Yuko Tazuke; Barbara E Wildhaber; Hua Yang; Joseph Washburn; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

Review 8.  Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease.

Authors:  Shishira Bharadwaj; Tushar Gohel; Omer J Deen; Robert DeChicco; Abdullah Shatnawei
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-04-08

9.  Isolated liver transplantation for treatment of liver failure secondary to intestinal failure.

Authors:  Maria Immacolata Spagnuolo; Eliana Ruberto; Alfredo Guarino
Journal:  Ital J Pediatr       Date:  2009-09-15       Impact factor: 2.638

10.  Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience.

Authors:  Ah-Young Kim; Ryoung-Kyoung Lim; Young-Mi Han; Kyung-Hee Park; Shin-Yun Byun
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.